Inspire Medical Systems, Inc. (NYSE:INSP) CTO John Rondoni Sells 583 Shares of Stock

Inspire Medical Systems, Inc. (NYSE:INSP) CTO John Rondoni sold 583 shares of the business’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total transaction of $99,395.67. Following the sale, the chief technology officer now directly owns 10,424 shares in the company, valued at approximately $1,777,187.76. The trade was a 5.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

John Rondoni also recently made the following trade(s):

• On Tuesday, January 7th, John Rondoni sold 58 shares of Inspire Medical Systems stock. The shares were sold at an average price of $215.00, for a total value of $12,470.00.

Inspire Medical Systems Stock Up 0.1 %

INSP opened at $187.23 on Friday. The stock has a market cap of $5.61 billion, a PE ratio of 174.98 and a beta of 1.32. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40. The company has a fifty day moving average of $189.20 and a 200-day moving average of $191.36.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. Sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Inspire Medical Systems

Large investors have recently added to or reduced their stakes in the business. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Inspire Medical Systems during the 3rd quarter worth approximately $1,929,000. Thrivent Financial for Lutherans boosted its stake in Inspire Medical Systems by 39.7% during the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company’s stock worth $23,337,000 after acquiring an additional 31,444 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Inspire Medical Systems by 798.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock worth $56,530,000 after purchasing an additional 238,034 shares during the period. Merit Financial Group LLC bought a new stake in Inspire Medical Systems in the fourth quarter valued at $313,000. Finally, Principal Financial Group Inc. increased its stake in Inspire Medical Systems by 3,812.6% in the third quarter. Principal Financial Group Inc. now owns 141,089 shares of the company’s stock valued at $29,777,000 after purchasing an additional 137,483 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on INSP. Wells Fargo & Company lowered their target price on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a report on Tuesday. Bank of America upgraded shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and raised their price objective for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Truist Financial reduced their target price on shares of Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating on the stock in a report on Tuesday. Piper Sandler dropped their price target on shares of Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Morgan Stanley reduced their price objective on shares of Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating on the stock in a research note on Tuesday. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $228.82.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.